Reversing dementia in mice sets stage for human clinical trials
New Atlas - 29-Jun-2021SAK3, the first compound to target the activity in neurodegenerative disorders
Kohji Fukunaga
Professor of Tohoku University
He is a Professor of Tohoku University and studied at Kumamoto University. His research interest include Neuropharmacology.
Visit website: https://www.researchgate.net/profile/Kohji-Fukunaga
See also
Details last updated 30-Jun-2021
Kohji Fukunaga News
